Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riviciclib for Radiation Induced Mucositis in Head and Neck Cancer
NCT01903018Phase 2Completed
- Sponsor
- Piramal Enterprises Limited
- Start
- Jul 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of P276 in radiation-induced mucositis (RIOM), sponsored by Piramal Enterprises Limited. Started Jul 2012; status: completed.
02
Drugs
P276
03
Conditions
radiation-induced mucositis (RIOM)
Beyond the preview
Go deeper on NCT01903018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01903018.